T/CRHA 110-2024 Tumor immunotherapy checkpoint inhibitors require nursing techniques that require specific care and attention

Scope

Scope: This document specifies the basic requirements, technical processes, drug evaluation, drug preparation, use, and adverse reaction management during the care process of tumor immune checkpoint inhibitors; Main technical content: The overall structure adopted by this document is as follows: 1. Scope; 2. Normative reference documents; 3. Terms and definitions; 4. Abbreviations; 5. Basic requirements; 6. Technical processes; 7. Pre-medication evaluation; 8. Drug preparation; 9. Drug use; 10. Adverse reaction management. This document is applicable to registered nurses in all levels and types of medical institutions for the treatment of tumors with immune checkpoint inhibitors.

Development Information

Related Standards